Skip to main content
FDA approves Xeris' treatment for hypoglycemia in diabetes
9/11/2019

Xeris Pharmaceuticals' glucagon therapy Gvoke, a treatment for hypoglycemia in patients with diabetes, has gained FDA approval. The pre-filled glucagon pen can be used in patients with diabetes ages 2 and older.

Full Story: